| Ident. | Authors (with country if any) | Title |
|---|
| 000212 (2020) |
Youchao Dai [République populaire de Chine] ; Yi Cai [République populaire de Chine] ; Xin Wang [République populaire de Chine] ; Jialou Zhu [République populaire de Chine] ; Xiaoqing Liu [République populaire de Chine] ; Houming Liu [République populaire de Chine] ; Linghua Li [République populaire de Chine] ; Yinze Zhang [République populaire de Chine] ; Shengze Liu [République populaire de Chine] ; Zhihua Wen [République populaire de Chine] ; Carl G. Feng [Australie] ; Xinchun Chen [République populaire de Chine] ; Xiaoping Tang [République populaire de Chine] | Autoantibody-Mediated Erythrophagocytosis Increases Tuberculosis Susceptibility in HIV Patients |
| 000219 (2020) |
Brittney S. Harrington [Australie] ; Yaowu He [Australie] ; Tashbib Khan [Australie] ; Simon Puttick [Australie] ; Paul J. Conroy [Australie] ; Thomas Kryza [Australie] ; Tahleesa Cuda [Australie] ; Kamil A. Sokolowski [Australie] ; Brian Wc Tse [Australie] ; Katherine K. Robbins [Australie] ; Buddhika J. Arachchige [Australie] ; Samantha J. Stehbens [Australie] ; Pamela M. Pollock [Australie] ; Sarah Reed [Australie] ; S. John Weroha [États-Unis] ; Paul Haluska [États-Unis] ; Carlos Salomon [Australie] ; Rohan Lourie [Australie] ; Lewis C. Perrin [Australie] ; Ruby H. P. Law [Australie] ; James C. Whisstock [Australie] ; John D. Hooper [Australie] | Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer |
| 000227 (2020) |
Christopher Kwan [Australie] ; Suzana Milosevic [Australie] ; Helen Benham [Australie] ; Ian A. Scott [Australie] | A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level |
| 000370 (2019) |
Marjorie Reyes-Farias [Espagne] ; Catalina Carrasco-Pozo [Australie] | The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism |
| 000467 (2019) |
Zhe Zhang [République populaire de Chine] ; Wei Gao [République populaire de Chine] ; Li Zhou [République populaire de Chine] ; Yan Chen [République populaire de Chine] ; Siyuan Qin [République populaire de Chine] ; Lu Zhang [République populaire de Chine] ; Jiayang Liu [République populaire de Chine] ; Yujia He [République populaire de Chine] ; Yunlong Lei [République populaire de Chine] ; Hai-Ning Chen [République populaire de Chine] ; Junhong Han [République populaire de Chine] ; Zong-Guang Zhou [République populaire de Chine] ; Edouard C. Nice [Australie] ; Changlong Li [République populaire de Chine] ; Canhua Huang [République populaire de Chine] ; Xiawei Wei [République populaire de Chine] | Repurposing Brigatinib for the Treatment of Colorectal Cancer Based on Inhibition of ER-phagy |
| 000707 (2019) |
Tu C. Le [Australie] ; Jiali Zhai [Australie] ; Wei-Hsun Chiu [Australie] ; Phong A. Tran [Australie] ; Nhiem Tran [Australie] | Janus particles: recent advances in the biomedical applications |
| 000755 (2019) |
Carla Proietti [Australie] ; Lutz Krause [Australie] ; Angela Trieu [Australie] ; Daniel Dodoo [Ghana] ; Ben Gyan [Ghana] ; Kwadwo A. Koram [Ghana] ; William O. Rogers ; Thomas L. Richie ; Peter D. Crompton [États-Unis] ; Philip L. Felgner [États-Unis] ; Denise L. Doolan [Australie] | Immune Signature Against Plasmodium falciparum Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities* |
| 000917 (2019) |
Stephanie Clare Blake [Australie] ; Benjamin Silas Daniel [Australie] | Cutaneous lupus erythematosus: A review of the literature☆ |
| 000A48 (2019) |
Kielan D. Mcalinden ; Deepak A. Deshpande [États-Unis] ; Saeid Ghavami [Canada] ; Dia Xenaki [Australie] ; Sukhwinder Singh Sohal [Australie] ; Brian G. Oliver [Australie] ; Mehra Haghi ; Pawan Sharma [Australie] | Autophagy Activation in Asthma Airways Remodeling. |
| 000A81 (2019) |
Ari Satia Nugraha [Australie] ; Yuvita Dian Damayanti ; Phurpa Wangchuk ; Paul A. Keller [Australie] | Anti-Infective and Anti-Cancer Properties of the Annona Species: Their Ethnomedicinal Uses, Alkaloid Diversity, and Pharmacological Activities |
| 000B07 (2019) |
Azad Saei [Suède] ; Pieter Johan Adam Eichhorn [Australie, Singapour] | Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma |
| 000B31 (2019) |
Jian-Da Ma [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jun-Wei Wang [République populaire de Chine] ; Tao Yan [République populaire de Chine] ; Qian-Hua Li [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Jin-Long Gao [Australie] ; Ky-Anh Nguyen [Australie] ; Lie Dai [République populaire de Chine] | A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients |
| 000C17 (2018) |
Oded Breuer [Australie] ; André Schultz [Australie] | Side effects of medications used to treat childhood interstitial lung disease. |
| 000D06 (2017) |
Magdalena Circu [États-Unis] ; James Cardelli [États-Unis] ; Martin P. Barr [Irlande (pays)] ; Kenneth O'Byrne [Australie] ; Glenn Mills [États-Unis] ; Hazem El-Osta [États-Unis] | Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells. |
| 000D28 (2017) |
Pawan Sharma [États-Unis] ; Roslyn Yi [États-Unis] ; Ajay P. Nayak [États-Unis] ; Nadan Wang [États-Unis] ; Francesca Tang [Australie] ; Morgan J. Knight [États-Unis] ; Shi Pan [États-Unis] ; Brian Oliver [Australie] ; Deepak A. Deshpande [États-Unis] | Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice. |
| 000D65 (2016) |
Lyn M. Moir [Australie] | Lymphangioleiomyomatosis: Current understanding and potential treatments. |
| 000D75 (2016) |
Hui Ren [République populaire de Chine] ; Hua Guo [République populaire de Chine] ; Asmitananda Thakur [République populaire de Chine] ; Shuo Zhang [République populaire de Chine] ; Ting Wang [République populaire de Chine] ; Yiqian Liang [République populaire de Chine] ; Puyu Shi [République populaire de Chine] ; Lei Gao [République populaire de Chine] ; Feng Liu [République populaire de Chine] ; Jing Feng [République populaire de Chine] ; Tianjun Chen [République populaire de Chine] ; Tian Yang [République populaire de Chine] ; Dong Shang [République populaire de Chine] ; Johnson J. Liu [Australie] ; Feng Xu [République populaire de Chine] ; Mingwei Chen [République populaire de Chine] | Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells. |
| 000D89 (2016) |
Teck Choon Tan [Singapour] ; Louise Wienholt [Australie] ; Stephen Adelstein [Australie] | TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia |
| 000E07 (2016) |
Erica J. Hines [Australie] ; Mark Walsh [Australie] ; Jane E. Armes [Australie] ; Tonia Douglas [Australie] ; Jasneek Chawla [Australie] | Interstitial lung disease in infancy: A general approach |
| 000E35 (2016) |
Jason Kg Tan [Australie] ; Conor Murray ; Andre Schultz [Australie] | ABCA3 lung disease in an ex 27 week preterm infant responsive to systemic glucocorticosteroids |
| 000E44 (2015-09-30) |
Serena Pulcini [Royaume-Uni] ; Henry M. Staines [Royaume-Uni] ; Andrew H. Lee [États-Unis] ; Sarah H. Shafik [Australie] ; Guillaume Bouyer [France] ; Catherine M. Moore [Royaume-Uni] ; Daniel A. Daley [États-Unis] ; Matthew J. Hoke [États-Unis] ; Lindsey M. Altenhofen [États-Unis] ; Heather J. Painter [États-Unis] ; Jianbing Mu [États-Unis] ; David J P. Ferguson [Royaume-Uni] ; Manuel Llinas [États-Unis] ; Rowena E. Martin [Australie] ; David A. Fidock [États-Unis] ; Roland A. Cooper [États-Unis] ; Sanjeev Krishna [Royaume-Uni] | Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite's food vacuole and alter drug sensitivities |
| 000E68 (2015) |
Chayawee Muangchan [Canada] ; Ronald F. Van Vollenhoven [Suède] ; Sasha R. Bernatsky [Canada] ; C Douglas Smith [Canada] ; Marie Hudson [Canada] ; Murat Inanç [Turquie] ; Naomi F. Rothfield ; Peter T. Nash [Australie] ; Richard A. Furie [États-Unis] ; Jean-Luc Senécal [Canada] ; Vinod Chandran [Canada] ; Ruben Burgos-Vargas [Mexique] ; Rosalind Ramsey-Goldman [États-Unis] ; Janet E. Pope [Canada] | Treatment Algorithms in Systemic Lupus Erythematosus. |
| 000E73 (2015) |
Yang Xi [Australie] ; Arvid Finlayson [Australie] ; Oliva J. White [Australie] ; Melanie L. Carroll [Australie] ; John W. Upham [Australie] | Rhinovirus stimulated IFN-α production: how important are plasmacytoid DCs, monocytes and endosomal pH? |
| 000F27 (2015) |
L. Cummins [Australie] ; V. S. Katikireddi [Australie] ; S. Shankaranarayana [Australie] ; K. Y. C. Su [Australie] ; E. Duggan [Australie] ; V. Videm [Australie, Norvège] ; H. Pahau [Australie] ; R. Thomas [Australie] | Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis |
| 000F65 (2015) |
Melissa Carroll [Australie] ; Nick Mellick [Australie] ; Godfrey Wagner [Australie] | Dermatomyositis panniculitis: A case report |
| 000F73 (2015) |
Neil J. Hime [Australie] ; Yvonne Zurynski [Australie] ; Dominic Fitzgerald [Australie] ; Hiran Selvadurai [Australie] ; Amy Phu [Australie] ; Marie Deverell [Australie] ; Elizabeth J. Elliott [Australie] ; Adam Jaffe [Australie] | Childhood interstitial lung disease: A systematic review |
| 000F78 (2015) |
Lorenzo Galluzzi [France, Italie] ; Federico Pietrocola [France] ; José Manuel Bravo-San Pedro [France] ; Ravi K. Amaravadi [États-Unis] ; Eric H. Baehrecke [États-Unis] ; Francesco Cecconi [Danemark, Italie] ; Patrice Codogno [France] ; Jayanta Debnath [États-Unis] ; David A. Gewirtz [États-Unis] ; Vassiliki Karantza [États-Unis] ; Alec Kimmelman [États-Unis] ; Sharad Kumar [Australie] ; Beth Levine [États-Unis] ; Maria Chiara Maiuri [France] ; Seamus J. Martin [Irlande (pays)] ; Josef Penninger [Autriche] ; Mauro Piacentini [Italie] ; David C. Rubinsztein [Royaume-Uni] ; Hans-Uwe Simon [Suisse] ; Anne Simonsen [Norvège] ; Andrew M. Thorburn [États-Unis] ; Guillermo Velasco [Espagne] ; Kevin M. Ryan [Royaume-Uni] ; Guido Kroemer [France] | Autophagy in malignant transformation and cancer progression |
| 001006 (2014) |
Chantal Donovan ; Mirjam Simoons ; James Esposito ; Jean Ni Cheong ; Meaghan Fitzpatrick ; Jane Elizabeth Bourke [Australie] | Rosiglitazone is a superior bronchodilator compared to chloroquine and β-adrenoceptor agonists in mouse lung slices. |
| 001064 (2014) |
Scott W. Graf [Australie] ; Vidya S. Limaye [Australie] ; Leslie G. Cleland [Australie] | Gemcitabine‐induced radiation recall myositis in a patient with dermatomyositis |
| 001127 (2013) |
Phurpa Wangchuk ; Wangchuk Phurpa [Australie] ; Paul A. Keller ; Stephen G. Pyne ; Wilford Lie ; Anthony C. Willis ; Roonglawan Rattanajak ; Sumalee Kamchonwongpaisan | A new protoberberine alkaloid from Meconopsis simplicifolia (D. Don) Walpers with potent antimalarial activity against a multidrug resistant Plasmodium falciparum strain. |
| 001261 (2013) |
Geoffrey Littlejohn [Australie, États-Unis] ; Lynden Roberts [Australie] ; Mark Arnold [Australie] ; Paul Bird [Australie] ; Simon Burnet [Australie] ; Julien De Jager [Australie] ; Hedley Griffiths [Australie] ; Dave Nicholls [Australie] ; James Scott [Australie] ; Jane Zochling [Australie] ; Kathleen E. Tymms [Australie] | A multi‐center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control |
| 001316 (2012) |
Leann Tilley [Australie, États-Unis] ; Susan A. Charman [Australie, États-Unis] ; Jonathan L. Vennerstrom [Australie, États-Unis] | Chapter 2 - Semisynthetic Artemisinin and Synthetic Peroxide Antimalarials |
| 001323 (2012) |
Clare Schofield ; Michael J. Sladden [Australie] | Ulcerative necrobiosis lipoidica responsive to colchicine |
| 001326 (2012) |
H. Ahmadzai ; M. C. Kiernan ; D. Wakefield [Australie] ; P. S. Thomas | Treatment of refractory neurosarcoidosis with TNF‐inhibitors: what lies ahead? |
| 001332 (2012) |
Niroshini M. Giles [Nouvelle-Zélande] ; Sweta Kumari [Nouvelle-Zélande] ; Bevan P. Gang [Nouvelle-Zélande] ; Chun W. W. Yuen [Australie] ; Emilie M. F. Billaud [Nouvelle-Zélande] ; Gregory I. Giles [Nouvelle-Zélande] | The Molecular Design of S‐Nitrosothiols as Photodynamic Agents for Controlled Nitric Oxide Release |
| 001348 (2012) |
J. B. Sartain [Australie] ; N. L. Anderson [Australie] ; J. J. Barry ; P. T. Boyd ; P. W. Howat | Rheumatic heart disease in pregnancy: cardiac and obstetric outcomes |
| 001358 (2012) |
V. S. Katikireddi [Australie] ; D. A. Kandiah [Australie] | Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy |
| 001362 (2012) |
P. Lees [Royaume-Uni] ; R. P. Hunter [États-Unis] ; P. T. Reeves [Australie] ; P. L. Toutain [France] | Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination |
| 001371 (2012) |
D. Tong [Australie] ; N. Manolios [Australie] ; G. Howe ; D. Spencer | New onset sarcoid‐like granulomatosis developing during anti‐TNF therapy: an under‐recognised complication |
| 001391 (2012) |
S. Visser [Australie] ; M. Martin [Australie] ; D. J. Serisier [Australie] | Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case Report |
| 001436 (2012) |
David Shi Hao Liu ; Emilio Mignanelli [Australie] | Acute surgical abdomen in an immunocompromised patient |
| 001494 (2011) |
Trent Conroy [Australie] ; Jin T. Guo [Australie] ; Roger G. Linington [États-Unis] ; Nicholas H. Hunt [Australie] ; Richard J. Payne [Australie] | Total Synthesis, Stereochemical Assignment, and Antimalarial Activity of Gallinamide A |
| 001531 (2011) |
Michael F. Good [Australie] | Our impasse in developing a malaria vaccine |
| 001553 (2011) |
D. S. A. Mcleod ; M. L. Woods ; D. A. Kandiah [Australie] | Immune reconstitution inflammatory syndrome manifesting as development of multiple autoimmune disorders and skin cancer progression |
| 001564 (2011) |
K. Montag [Australie] ; M. Gingold [Australie] ; A. Boers [Australie] ; G. Littlejohn [Australie] | Disease‐modifying anti‐rheumatic drug usage, prescribing patterns and disease activity in rheumatoid arthritis patients in community‐based practice |
| 001571 (2011) |
Amy R. Wyatt [Australie] ; Justin J. Yerbury [Australie] ; Paula Berghofer [Australie] ; Ivan Greguric [Australie] ; Andrew Katsifis [Australie] ; Christopher M. Dobson [Royaume-Uni] ; Mark R. Wilson [Australie] | Clusterin facilitates in vivo clearance of extracellular misfolded proteins |
| 001573 (2011) |
M. Dugar [Australie] ; S. Cox ; V. Limaye ; P. Blumbergs ; P. J. Roberts-Thomson [Australie] | Clinical heterogeneity and prognostic features of South Australian patients with anti‐synthetase autoantibodies |
| 001586 (2011) |
Eva M. Luther [Allemagne] ; Yvonne Koehler [Allemagne] ; Joerg Diendorf [Allemagne] ; Matthias Epple [Allemagne] ; Ralf Dringen [Allemagne, Australie] | Accumulation of silver nanoparticles by cultured primary brain astrocytes |
| 001680 (2010) |
M. C. Kennedy [Australie] | Post‐mortem drug concentrations |
| 001689 (2010) |
S. J. Butterly ; P. Pillans [Australie] ; B. Horn [Australie] ; R. Miles ; J. Sturtevant | Off‐label use of rituximab in a tertiary Queensland hospital |
| 001793 (2009) |
Cyrus Daneshvar [Malaisie] ; Timothy M. E. Davis [Australie] ; Janet Cox-Singh [Malaisie] ; Mohammad Zakri Rafa'Ee [Malaisie] ; Siti Khatijah Zakaria [Malaisie] ; Paul C. S. Divis [Malaisie] ; Balbir Singh [Malaisie] | Clinical and Laboratory Features of Human Plasmodium knowlesi Infection |
